Thistory Biomedical closes Series B worth more than RMB 100 million

Shenzhen Thistory Biomedical Co., Ltd. announced that it had completed Series B round of financing with more than 100 million yuan, led by Sherpavc Investment, and followed by CMAF Shenzhen.

2020-09-08
|
Lynn Lin

Forerunner Medical closes Series B with hundreds of million in RMB

Forerunner Medical, a medical device technology company, recently announced that it had raised hundreds of millions of yuan in its Series B round of financing; which was led by CICC Capital, and followed by Cenova Capital, Apricot Capital, Dalton...

2020-09-08
|
Lynn Lin

Funstory.ai raises tens of millions of yuan in Series A+

Funstory.ai recently announced the completion of its Series A+ round of financing worth tens of millions of yuan, which was invested by NBT Capital. At the end of last year, Funstory.ai had already received tens of millions of yuan in its Series A,...

2020-09-05
|
Lynn Lin

China Isotope & Radiation Corporation and Bayer agree to introduce Xofigo into China

On September 1, China Isotope & Radiation Corporation (CIRC) signed an exclusive distribution agreement with Bayer.

2020-09-02
|
ChinaMedical

MYbank upgrades supply chain finance

On September 1, MYbank released its supply chain finance development status for the first time. It shows that the epidemic is significantly accelerating the speed at which the consumer goods industry embraces the Internet.

2020-09-02
|
ChinaFinance

Huichuang Medical completes tens of millions of yuan in Series A financing

The brain function medical equipment company Huichuang Medical has recently completed tens of millions of yuan in Series A financing. This round of financing was led by Tsing-yuan Capital.

2020-09-02
|
ChinaPEVC

SMIC releases its 2020 semi-annual report, net profit soared 556%

On the evening of August 27, China's largest semiconductor manufacturing company SMIC announced its interim results.

2020-08-30
|
ChinaTech

Advanced Micro: 291.98% YoY increase in net profit in H1 2020

Advanced Micro announced that it achieved a net profit of 119 million yuan in the first half of this year, a year-on-year increase of 291.98%.

2020-08-29
|
Michael Liang

What is the difference between Honor and Huawei?

Why are the prices of Huawei phones and Honor phones so different? What is the difference between the Huawei and Honor mobile phone? This article talks about the origins and differences between the Huawei and its Honor brand.

2020-08-28
|
Michael Liang

Ningmengdou.com closes Series A with RMB 50 mln

Recently, Ningmengdou.com, an industrial Internet platform under Qingdao Ningdou Network Technology Co., Ltd., has raised a total of 50 million yuan in its Series A round of financing from well-known investment institutions and industry investors...

2020-08-27
|
Lynn Lin

Sdpjw.cn closes Series B with tens of millions of yuan

Sdpjw.cn, a supply chain bill financial service platform, recently announced that it had received tens of millions of yuan in its Series B round of financing that would be mainly used for the R&D of new products and the construction of market basic...

2020-08-27
|
Lynn Lin

XYZ Robotics closes Series A+ with USD 20 mln

XYZ Robotics, a technology company dedicated to the application of robot hand-eye coordination, announced the completion of its Series A+ round of financing led by Source Code Capital, raising approximately 20 million US dollars.

2020-08-27
|
Lynn Lin

Governance Solutions Group obtains equity investment from Shanghai Finance Institute

Governance Solutions Group, or GSG announced on August 24 that it had obtained direct equity investment from Shanghai Finance Institute, SFI, which was an non-governmental, non-profit financial professional think tank for policy research in the fields...

2020-08-27
|
Lynn Lin

ACTOYS wholly acquired by Bilibili

On August 18, Jinan Yifulai Network Technology Co., Ltd., or ACTOYS, was undergoing some changes of the company’s industrial and commercial information. The original shareholders including Ganbei Capital, Sanqian Capital, and Gongqingcheng Shangqi...


Xuanzhu Biopharm closes RMB 800 mln Series A

Xuanzhu Biopharm, an innovative drug research and development company, recently has completed its Series A round of financing, raising 800 million yuan from SDIC.

2020-08-27
|
Lynn Lin
China SDG